Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- Author
- VERMA, Sunil1 ; MILES, David2 ; LIANG FANG10 ; LU, Michael W10 ; OLSEN, Steven10 ; BLACKWELL, Kim11 ; GIANNI, Luca3 ; KROP, Ian E4 ; WELSLAU, Manfred5 ; BASELGA, Jose6 ; PEGRAM, Mark7 ; OH, Do-Youn8 ; DIERAS, Véronique9 ; GUARDINO, Ellie10
[1] Sunnybrook Odette Cancer Centre, Toronto, Canada
[2] Mount Vernon Cancer Centre, Northwood, United Kingdom
[3] San Raffaele Hospital, Milan, Italy
[4] Dana― Farber Cancer Institute, United States
[5] Massachusetts General Hospital, Boston, United States
[6] Medical Office Hematology, Aschaffenburg, Germany
[7] University of Miami Sylvester Comprehensive Cancer Center, Miami, United States
[8] Seoul National University College of Medicine, Seoul, Korea, Republic of
[9] Institut Curie, Paris, France
[10] Genentech, South San Francisco, CA, United States
[11] Duke University Medical Center, Durham, NC, United States
EMILIA Study USGroup - Source
The New England journal of medicine. 2012, Vol 367, Num 19, pp 1783-1791, 9 p ; ref : 15 ref
- CODEN
- NEJMAG
- ISSN
- 0028-4793
- Scientific domain
- General medicine general surgery
- Publisher
- Massachusetts Medical Society, Waltham, MA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Anticorps monoclonal Cancer du sein Glande mammaire Gène erbB2 Gène onc cellulaire Immunomodulateur Médecine Protooncogène Stade avancé Trastuzumab Tumeur maligne Anti-HER2 Récepteur HER2 Cancer Pathologie de la glande mammaire Pathologie du sein
- Keyword (en)
- Antineoplastic agent Monoclonal antibody Breast cancer Mammary gland erbB2 Gene C-Onc gene Immunomodulator Medicine Protooncogene Advanced stage Trastuzumab Malignant tumor Human Epidermal growth factor Receptor 2 Cancer Mammary gland diseases Breast disease
- Keyword (es)
- Anticanceroso Anticuerpo monoclonal Cáncer del pecho Glándula mamaria Gen erbB2 Gen onc celular Inmunomodulador Medicina Protooncogen Estadio avanzado Trastuzumab Tumor maligno Cáncer Glándula mamaria patología Seno patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20E Mammary gland diseases / 002B20E02 Tumors
- Discipline
- Generalities in medical sciences Gynecology. Andrology. Obstetrics
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 26561206
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1056/NEJMoa1209124 
https://dx.doi.org/10.1056/NEJMoa1209124
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1209124\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:62:\"Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"367\";s:8:\"\u0000*\u0000issue\";s:2:\"19\";s:8:\"\u0000*\u0000spage\";s:4:\"1783\";s:8:\"\u0000*\u0000epage\";s:4:\"1791\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"VERMA\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Sunil\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:12:\"MILES, David\";i:1;s:10:\"LIANG FANG\";i:2;s:13:\"LU, Michael W\";i:3;s:13:\"OLSEN, Steven\";i:4;s:14:\"BLACKWELL, Kim\";i:5;s:12:\"GIANNI, Luca\";i:6;s:11:\"KROP, Ian E\";i:7;s:16:\"WELSLAU, Manfred\";i:8;s:13:\"BASELGA, Jose\";i:9;s:12:\"PEGRAM, Mark\";i:10;s:11:\"OH, Do-Youn\";i:11;s:18:\"DIERAS, V\u00e9ronique\";i:12;s:15:\"GUARDINO, Ellie\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:62:\"Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1209124\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:62:\"Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"367\";s:8:\"\u0000*\u0000issue\";s:2:\"19\";s:8:\"\u0000*\u0000spage\";s:4:\"1783\";s:8:\"\u0000*\u0000epage\";s:4:\"1791\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"VERMA\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Sunil\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:12:\"MILES, David\";i:1;s:10:\"LIANG FANG\";i:2;s:13:\"LU, Michael W\";i:3;s:13:\"OLSEN, Steven\";i:4;s:14:\"BLACKWELL, Kim\";i:5;s:12:\"GIANNI, Luca\";i:6;s:11:\"KROP, Ian E\";i:7;s:16:\"WELSLAU, Manfred\";i:8;s:13:\"BASELGA, Jose\";i:9;s:12:\"PEGRAM, Mark\";i:10;s:11:\"OH, Do-Youn\";i:11;s:18:\"DIERAS, V\u00e9ronique\";i:12;s:15:\"GUARDINO, Ellie\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:62:\"Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1209124\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1209124\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:62:\"Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"367\";s:8:\"\u0000*\u0000issue\";s:2:\"19\";s:8:\"\u0000*\u0000spage\";s:4:\"1783\";s:8:\"\u0000*\u0000epage\";s:4:\"1791\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"VERMA\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Sunil\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:12:\"MILES, David\";i:1;s:10:\"LIANG FANG\";i:2;s:13:\"LU, Michael W\";i:3;s:13:\"OLSEN, Steven\";i:4;s:14:\"BLACKWELL, Kim\";i:5;s:12:\"GIANNI, Luca\";i:6;s:11:\"KROP, Ian E\";i:7;s:16:\"WELSLAU, Manfred\";i:8;s:13:\"BASELGA, Jose\";i:9;s:12:\"PEGRAM, Mark\";i:10;s:11:\"OH, Do-Youn\";i:11;s:18:\"DIERAS, V\u00e9ronique\";i:12;s:15:\"GUARDINO, Ellie\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:62:\"Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1209124\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:62:\"Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"367\";s:8:\"\u0000*\u0000issue\";s:2:\"19\";s:8:\"\u0000*\u0000spage\";s:4:\"1783\";s:8:\"\u0000*\u0000epage\";s:4:\"1791\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"VERMA\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Sunil\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:12:\"MILES, David\";i:1;s:10:\"LIANG FANG\";i:2;s:13:\"LU, Michael W\";i:3;s:13:\"OLSEN, Steven\";i:4;s:14:\"BLACKWELL, Kim\";i:5;s:12:\"GIANNI, Luca\";i:6;s:11:\"KROP, Ian E\";i:7;s:16:\"WELSLAU, Manfred\";i:8;s:13:\"BASELGA, Jose\";i:9;s:12:\"PEGRAM, Mark\";i:10;s:11:\"OH, Do-Youn\";i:11;s:18:\"DIERAS, V\u00e9ronique\";i:12;s:15:\"GUARDINO, Ellie\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:62:\"Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1209124\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:62:\"Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"367\";s:8:\"\u0000*\u0000issue\";s:2:\"19\";s:8:\"\u0000*\u0000spage\";s:4:\"1783\";s:8:\"\u0000*\u0000epage\";s:4:\"1791\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"VERMA\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Sunil\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:12:\"MILES, David\";i:1;s:10:\"LIANG FANG\";i:2;s:13:\"LU, Michael W\";i:3;s:13:\"OLSEN, Steven\";i:4;s:14:\"BLACKWELL, Kim\";i:5;s:12:\"GIANNI, Luca\";i:6;s:11:\"KROP, Ian E\";i:7;s:16:\"WELSLAU, Manfred\";i:8;s:13:\"BASELGA, Jose\";i:9;s:12:\"PEGRAM, Mark\";i:10;s:11:\"OH, Do-Youn\";i:11;s:18:\"DIERAS, V\u00e9ronique\";i:12;s:15:\"GUARDINO, Ellie\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:62:\"Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
